year as the patient was too ill to withstand an operation for its removal. 2 Although knots in pulmonary artery flotation catheters are rare, there are many reports of them in the literature and of their successful removal, either by drawing the knot tight and then pulling them through a venotomi or by using guidewires to unknot the catheter. 4 A knot around an intracardiac structure is more serious. It cannot be pulled out without cardiac damage. Although this case was not a true knot it behaved like one in that the catheter entangled with an intracardiac structure and could not be withdrawn. It was fortunate that in this case the patient was about to have coronary artery bypass grafting and so disentangling techniques were not attempted. It is hard to envisage how they could have succeeded.
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This case may well have been avoided if the catheter had been withdrawn before it reached 42 cm and had not entered the right ventricle. It would seem that the catheter looped in the atrium and a loop of catheter subsequently crossed the tricuspid valve allowing the balloon to spiral behind the papillary muscle of the anterior leaflet and cross itself upstream of where it passed behind the papillary muscle. When withdrawal was attempted the catheter pulled up on itself and probably kinked similarly to Figure 2 . We would recommend that if a pulmonary artery flotation catheter has not crossed the expected landmark at the appropriate distance it should be withdrawn and re-attempted. It is commonly taught that the pulmonary valve should be crossed 10-12 cm after the tricuspid valve. It seems that this principle should also apply for the tricuspid valve to be crossed within the appropriate distance of the insertion site. 'Harmless' passage down the inferior vena cava cannot be assumed. REFERENCES mid-thoracic back pain with evolving lower limb weakness and sensory loss. A solitary lung carcinoid tumour had been resected three years earlier. At the time of this presentation she had documented liver, lymph node, and breast metastases. She had been treated for the past four years for mild hypertension with pindolol and now complained of episodes of flushing and diarrhoea. Her urinary 5-hydroxy indole acetic acid (5-HIAA) was elevated.
Examination revealed a sixty-five kilogram woman with obvious facial flushing and signs of spinal cord compression below the fourth thoracic level.
Anaesthesia
Premedication was omitted at the patient's request. Octreotide was given to inhibit the release of mediators from the tumour at induction and intraoperatively. We used 100 Ilg intravenously twenty minutes prior to induction and 100 Ilg subcutaneously at induction.
Intra-arterial pressure monitoring was established under local anaesthesia with a radial arterial line. Other monitoring included ECG, capnography, pulse oximetry, peripheral nerve stimulator, oesophageal stethoscope, and temperature probe. Following three minutes' pre-oxygenation a careful, cardio-stable induction was given using alfentanil 5 mg, thiopentone 250 mg and vecuronium 8 mg. Ventilation was maintained by face mask and bag using nitrous oxide 65% and oxygen 35%. As mask ventilation was begun, her blood pressure rose from 160/90 to 250/110 mmHg, her pulse increased from 90 to 130 per minute and she became noticeably sweaty. Ventilation with isoflurane 2% for two minutes had no effect on this hypertensive crisis. Ketanserin given as a 10 mg bolus intravenously smoothly resolved the crisis, with systolic blood pressure falling to 180 mmHg and pulse slowing to 65 per minute over the next three minutes. Intubation was then achieved without further rise of blood pressure or pulse.
Anaesthesia was maintained using isoflurane 0.5% and nitrous oxide 65% in oxygen. V~entilation was adjusted to maintain an end-tidal carbon dioxide concentration of 4.0-4.7%. Vecuronium in incremental doses was used for relaxation and analgesia obtained with fentanyl to a total dose of 300 Ilg for the 90 minutes of surgery. An infusion of ketanserin at 5 mg/hr maintained her systolic blood pressure at 110-140 mmHg. Recovery from anaesthesia was uneventful. Octreotide treatment was maintained for 72 hours after operation.
DISCUSSION
Acute carcinoid crisis intraoperatively may be treated by either blocking the release of mediators from the tumour or by blocking the action of the mediators. 1 Somatostatin inhibits the release of mediators from carcinoid tumours and effectively controls intraoperative hypotension and bronchospasm. As it has a very short plasma half-life (2.3 minutes for somatostatin-14) and rebound effects occur unless it is given by continuous infusion. 2 Octreotide, a long-acting somatostatin analogue, has been used successfully as the sole agent to decrease the storage and release of mediators in the perioperative period. Octreotide, 100 Ilg subcutaneously, two or three times daily for two weeks prior to surgery with 100 Ilg 'intravenously at induction, and slow weaning over several days postoperatively, has been advocated for management of carcinoid patients. l Octreotide has no 'important' side effects. 3 The pharmacokinetics of octreotide show mean plasma elimination half-lives of 100 minutes after subcutaneous injection of 100 Ilg and after intravenous injection of 100 Ilg a biphasic elimination with half-lives of 10 and 90 minutes respectively.4 Octreotide is registered for use in Australia. (J. Rawlins, personal communication, 1989.)
In the case presented, octreotide pretreatment was not possible due to its urgency, and a hypertensive crisis occurred, even though octreotide had been given at induction. Ketanserin was then chosen, as the most appropriate agent, to control the hypertension.
Ketanserin is a selective antagonist at 5-HT2 receptors, alpha-l adrenoceptors, H 1histamine receptors, and has an effect of decreasing the central sympathetic outflow. 5 The unique pharmacological profile of ketanserin may underlie its efficacy in hypertensive carcinoid crisis.
Carcinoid tumours release 5-hydroxytryptamine,5 which amplifies vasoconstrictor responses of blood vessels to catecholamines by stimulating the release of noradrenaline, inhibiting the uptake of noradrenaline and potentiating the postjunctional alpha-l adrenoceptor-mediated responses to noradrenaline and adrenaline. 6 . 7 5-hydroxytryptamine is a positive inotrope and chronotrope. 6 The release of 5-HT from carcinoid tumours is, in turn, stimulated by alpha or beta-adrenoceptor agonists. 8 At induction of anaesthesia a hypertensive carcinoid crisis could occur both from stress and from catecholamines stimulating carcinoid tumour cells to release 5-HT, which in turn potentiate the responses to the circulating catecholamines. Ketanserin's dual blocking of vascular alpha-I adrenoceptors and 5-HT 2 receptors might well explain its efficacy in controlling a hypertensive crisis that was refractory to high-dose opiates and isoflurane.
Ketanserin provides a useful tool in the management of patients with carcinoid syndrome, having a long-term effect in controlling symptoms,9 providing haemodynamic stability in anaesthetised patients with high circulating levels of 5-HT, 10 and controlling blood pressure during acute hypertensive crisis. 11 Intraoperative ketanserin 10 mg prior to sternotomy has no adverse effects, 12 but minor adverse effects are reported with long-term oral therapy. 13 The pharmacokinetics of ketanserin show a plasma elimination half-life of 14.3 hours following a 10 mg intravenous bolus. 14 The onset of clinical action occurs within five minutes of a similar intravenous bolus. 12 Ketanserin is available in Australasia, but is not yet registered at the time of preparation of this manuscript. (J. Mills, personal communication.)
Previous management regimes for carcinoid syndrome involving bradykinin inhibitors have failed to function effectively. IS Drugs such as cyproheptadine and methysergide are agonist-antagonists at 5-HT receptors and may not adequately block responses to 5_HT. IO • IS H I and H2-histamine receptor antagonists may be useful premedicants to block the intraoperative effects of histamine release from tumour cells . 16 In summary, this case demonstrates the combined use of ketanserin and octreotide to control an acute hypertensive carcinoid crisis in an unprepared patient with carcinoid syndrome. To avoid carcinoid cnSlS during the operative period, adequate pre-treatment with octreotide should provide protection. I Similarly, it would be wise to premedicate with HI and H2-histamine antagonists, and drugs known to release histamine should be avoided. Ketanserin may best control a hypertensive crisis should it occur.
The combined use of octreotide and ketanserin described in this report may not be the only successful way of managing such a patient but probably represents the most appropriate use of the two new drugs with our present knowledge of carcinoid syndrome, its physiology and pharmacology. Postoperative and post-traumatic pain often presents management difficulties. The use of local anaesthesia for regional or plexus block has been shown, in some situations, to have advantages over conventional methods of pain relief. I Our patient presented with post-traumatic leg pain which was inadequately relieved by opioids. Control of the pain was achieved by repeated injections of local anaesthetic drug through a catheter placed near the sciatic nerve.
Pain Relief with Bupivacaine Given Through a Sciatic Nerve Catheter
CASE HISTORY A 28-year-old man was transferred from a country hospital because of multiple injuries sustained in a motor vehicle accident. These injuries included a suspected ruptured spleen and numerous fractures. He was resuscitated and transferred to the Royal Adelaide
